- Home
- SGMO vs XNET Comparison
SGMO vs XNET Comparison
Compare SGMO & XNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- XNET
- Stock Information
- Founded
- SGMO 1995
- XNET 2003
- Country
- SGMO United States
- XNET China
- Employees
- SGMO N/A
- XNET N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- XNET Computer Software: Prepackaged Software
- Sector
- SGMO Health Care
- XNET Technology
- Exchange
- SGMO Nasdaq
- XNET Nasdaq
- Market Cap
- SGMO 242.0M
- XNET 206.0M
- IPO Year
- SGMO 2000
- XNET 2014
- Fundamental
- Price
- SGMO $1.07
- XNET $3.13
- Analyst Decision
- SGMO Buy
- XNET
- Analyst Count
- SGMO 6
- XNET 0
- Target Price
- SGMO $5.17
- XNET N/A
- AVG Volume (30 Days)
- SGMO 3.8M
- XNET 346.0K
- Earning Date
- SGMO 03-12-2025
- XNET 03-13-2025
- Dividend Yield
- SGMO N/A
- XNET N/A
- EPS Growth
- SGMO N/A
- XNET 146.84
- EPS
- SGMO N/A
- XNET 0.23
- Revenue
- SGMO $52,291,000.00
- XNET $359,611,000.00
- Revenue This Year
- SGMO N/A
- XNET N/A
- Revenue Next Year
- SGMO N/A
- XNET N/A
- P/E Ratio
- SGMO N/A
- XNET $13.83
- Revenue Growth
- SGMO N/A
- XNET 99.13
- 52 Week Low
- SGMO $0.30
- XNET $1.45
- 52 Week High
- SGMO $3.18
- XNET $3.75
- Technical
- Relative Strength Index (RSI)
- SGMO 37.60
- XNET 60.15
- Support Level
- SGMO $1.07
- XNET $2.88
- Resistance Level
- SGMO $1.24
- XNET $3.75
- Average True Range (ATR)
- SGMO 0.09
- XNET 0.29
- MACD
- SGMO 0.02
- XNET 0.02
- Stochastic Oscillator
- SGMO 5.71
- XNET 56.34
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About XNET Xunlei Limited
Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.